Clinical Trial

Evaluation of ICP-B208 in Patients With Advanced Solid Tumors

Name: Evaluation of ICP-B208 in Patients With Advanced Solid Tumors — clinical trial record (NCT07617493)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

To evaluate the safety, tolerability, efficacy and pharmacokinetic characteristics of ICP-B208 in the trial participants of unresectable advanced or metastatic solid tumors

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-11

Trial Details

NCT Number	NCT07617493
Lead Sponsor	Beijing InnoCare Pharma Tech Co., Ltd.
Conditions	Advanced Solid Tumor
Enrollment	539 participants
Start Date	2026-07-03
Primary Completion	2030-12 (estimated)
Study Completion	2031-06 (estimated)
Updated on ClinicalTrials.gov	2026-07-10